Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Photodynamic therapy using 5-aminolevulinic acid (ALA)-induced protoporphyrin IX (PpIX) may be applied to the treatment of neoplasms in a variety of organs. In order to enhance existing regimens of photodynamic therapy, we investigated the effects of adding differentiation therapy to photodynamic therapy in human prostate cancer cells in vitro. The objective of differentiation therapy per se is to reverse the lack of differentiation in cancer cells using pharmacological agents. The motivation for this study was to exploit the differentiation-dependent expression of some heme enzymes to enhance tumour cell toxicity of ALA-photodynamic therapy. A short course of differentiation therapy was applied to increase PpIX formation during subsequent ALA exposure. Using the synthetic androgen R1881, isomers of retinoic acid, and analogues of vitamin D for 3 to 4 days, exogenous ALA-dependent PpIX formation in LNCaP cells was increased, along with markers for growth arrest and for differentiation. As a consequence of higher PpIX levels, cytotoxic effects of visible light exposure were also enhanced. Short-term differentiation therapy increased not only the overall PpIX production but also reduced that fraction of cells that contained low PpIX levels as demonstrated by flow cytometry and fluorescence microscopy. This study suggests that it will be feasible to develop protocols combining short-term differentiation therapy with photodynamic therapy for enhanced photosensitisation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CCAAT-Enhancer Binding Protein: A Component of a Differentiation Switch
Umek, R. M., Friedman, A. D., & McKnight, S. L. (1991) · Science · doi:10.1126/science.1987644 · Cited by 712
A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin
Iinuma, S., Farshi, S., Ortel, B., & Hasan, T. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.244 · Cited by 240
Self-citationRittenhouse‐Diakun, K., Leengoed, H. V., Morgan, J., Hryhorenko, E., Paszkiewicz, G., Whitaker, J. E., & Oseroff, A. R. (1995) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1995.tb02356.x · Cited by 124 · cited 1×
“Similarly, larger amounts of PpIX were accumulated in lectin-stimulated lymphocytes, than in non-stimulated, non-dividing cells (Rittenhouse-Diakun et al, 1995).”
Background
Cited by
Milestones in the development of photodynamic therapy and fluorescence diagnosis
Juzeniene, A., Peng, Q., & Moan, J. (2007) · Photochemical & Photobiological Sciences · doi:10.1039/b705461k · Cited by 273
Yang, X., Palasuberniam, P., Kraus, D., & Chen, B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025865 · Cited by 158
“Calcitriol treatment increases E-cadherin and Ki67 staining, up-regulates CPOX and down-regulates FECH, leading to ALA-PpIX accumulation [61].”
BackgroundSinha, A. K., Anand, S., Ortel, B. J., Chang, Y., Mai, Z., Hasan, T., & Maytin, E. V. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603273 · Cited by 114
“1( ) vector transfected into cos-7 cells (see Figure 7C).”
BackgroundMethodInfluentialSelf-citationValdés, P. A., Samkoe, K., O’Hara, J. A., Roberts, D. W., Paulsen, K. D., & Pogue, B. W. (2010) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2009.00664.x · Cited by 48
Metadata
- Authors
- Ortel, B., Sharlin, D., O'Donnell, D., Sinha, A. K., Maytin, E. V., & Hasan, T.
- Venue
- British Journal of Cancer
- Published
- 2002-11
- Volume
- 87
- Issue
- 11
- Pages
- 1321-1327
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2052609407
- Cited by
- 79
- References
- 3
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.